SARS-CoV-2 Infection

Showing NaN - NaN of 8

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

COVID-19, SARS-CoV-2 Infection, Coronavirus Infection Trial in United States (TXA127, TRV027, Placebo)

Recruiting
  • COVID-19
  • +2 more
  • Birmingham, Alabama
  • +67 more
Aug 2, 2022

COVID-19, SARS-CoV-2 Infection Trial in United States (NVX-Cov2373)

Active, not recruiting
  • COVID-19
  • SARS-CoV-2 Infection
  • Long Beach, California
  • +30 more
Jul 18, 2022

SARS-CoV-2 Infection, COVID-19 Trial in Worldwide (BNT162b2, Placebo, BNT162b2 OMI)

Recruiting
  • SARS-CoV-2 Infection
  • COVID-19
  • BNT162b2
  • +4 more
  • Athens, Alabama
  • +158 more
Jul 18, 2022

COVID on Children and Families

Recruiting
  • SARS-CoV-2 Infection
    • Birmingham, Alabama
    • +64 more
    May 5, 2022

    SARS-CoV-2 Infection Trial in Worldwide (Intramuscular injection, Intramuscular vaccine)

    Active, not recruiting
    • SARS-CoV-2 Infection
    • Intramuscular injection
    • Intramuscular vaccine
    • Birmingham, Alabama
    • +90 more
    Apr 4, 2022

    Pneumococcal Disease, COVID-19, SARS-CoV-2 Infection Trial in United States (20-valent pneumococcal conjugate vaccine (20vPnC),

    Completed
    • Pneumococcal Disease
    • +2 more
    • 20-valent pneumococcal conjugate vaccine (20vPnC)
    • +2 more
    • Anaheim, California
    • +28 more
    Mar 23, 2022

    SARS-CoV-2 Infection, COVID-19 Trial in United States (BNT162b2)

    Completed
    • SARS-CoV-2 Infection
    • COVID-19
    • BNT162b2
    • Anaheim, California
    • +20 more
    Feb 17, 2022

    Covid19, Coronavirus, SARS-CoV-2 Infection Trial in United States (Rayaldee 30Mcg Extended-Release (ER) Capsule, Placebo)

    Completed
    • Covid19
    • +2 more
    • Rayaldee 30Mcg Extended-Release (ER) Capsule
    • Placebo
    • San Francisco, California
    • +9 more
    Oct 14, 2021